Dan brings to Repertoire more than 15 years of experience developing and commercializing platforms. Previously, he served as SVP, Head of Platform at Cogen Immune Medicine, which was merged with Torque Therapeutics to form Repertoire. Prior to joining Cogen, Dan co-founded Firefly BioWorks, where he served as President and Chief Technology Officer from inception through the company’s acquisition by Abcam in 2015. In this capacity, he led the ideation and productization of the FirePlex Platform used for the direct, highly-multiplexed quantification of microRNAs and cytokines in biofluids. Dan earned his PhD from the Department of Chemical Engineering at the Massachusetts Institute of Technology.